Maxillonasal dysplasia

Maxillonasal dysplasia, also known as Binder syndrome or Binder type maxillonasal dysplasia, is a rare congenital craniofacial malformation primarily affecting the midface. The condition is characterized by an underdeveloped (hypoplastic) nose and maxilla (upper jaw), resulting in a distinctive flat facial profile. Key features include a flat or absent nasal bridge, short columella (the tissue between the nostrils), an acute nasolabial angle, a convex upper lip, and a relatively prognathic (protruding) lower jaw giving a Class III malocclusion appearance. The nasal bones and the anterior nasal spine are typically hypoplastic or absent. Some patients may also have mild hearing difficulties or vertebral anomalies, particularly in the cervical spine. The condition is present from birth and is usually recognized in infancy or early childhood based on the characteristic facial appearance. Intelligence and overall development are typically normal. The exact etiology remains unclear in most cases, though it has been associated with prenatal exposure to certain teratogens (such as warfarin or phenytoin) and with chondrodysplasia punctata. Most cases appear to occur sporadically, though rare familial cases have been reported, suggesting possible autosomal recessive inheritance in some instances. Treatment is primarily surgical and focuses on correcting the cosmetic and functional abnormalities of the midface. Surgical interventions may include rhinoplasty with bone or cartilage grafting to augment the nasal bridge, orthognathic surgery to correct jaw alignment, and orthodontic treatment to address malocclusion. Timing of surgical correction is individualized, often performed during adolescence when facial growth is nearing completion. With appropriate surgical management, outcomes are generally favorable, and patients can achieve significant improvement in both facial appearance and function.

Common questions about Maxillonasal dysplasia